Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06970301) titled 'A Study to Assess the Safety and Tolerability, and Pharmacokinetics of UCB0022 in Healthy Caucasian, Japanese, and Chinese Participants' on May 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: UCB Biopharma SRL
Condition:
Healthy Study Participants
Intervention:
Drug: glovadalen
Recruitment Status: Recruiting
Phase: Phase 1
Date of First Enrollment: April 28, 2025
Target Sample Size: 32
Countries of Recruitment:
Un...